• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有缺失标记的分层标记特定比例风险模型中相对失败率的推断及其在HIV疫苗疗效试验中的应用

Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials.

作者信息

Gilbert Peter B, Sun Yanqing

机构信息

Department of Biostatistics, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Department of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.

出版信息

J R Stat Soc Ser C Appl Stat. 2015 Jan 1;64(1):49-73. doi: 10.1111/rssc.12067.

DOI:10.1111/rssc.12067
PMID:25641990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4310507/
Abstract

This article develops hypothesis testing procedures for the stratified mark-specific proportional hazards model in the presence of missing marks. The motivating application is preventive HIV vaccine efficacy trials, where the mark is the genetic distance of an infecting HIV sequence to an HIV sequence represented inside the vaccine. The test statistics are constructed based on two-stage efficient estimators, which utilize auxiliary predictors of the missing marks. The asymptotic properties and finite-sample performances of the testing procedures are investigated, demonstrating double-robustness and effectiveness of the predictive auxiliaries to recover efficiency. The methods are applied to the RV144 vaccine trial.

摘要

本文针对存在缺失标记情况下的分层标记特定比例风险模型,开发了假设检验程序。其动机应用是预防性HIV疫苗疗效试验,其中标记是感染的HIV序列与疫苗中所代表的HIV序列的遗传距离。检验统计量基于两阶段有效估计量构建,该估计量利用了缺失标记的辅助预测变量。研究了检验程序的渐近性质和有限样本性能,证明了预测辅助变量在恢复效率方面的双重稳健性和有效性。这些方法应用于RV144疫苗试验。

相似文献

1
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials.具有缺失标记的分层标记特定比例风险模型中相对失败率的推断及其在HIV疫苗疗效试验中的应用
J R Stat Soc Ser C Appl Stat. 2015 Jan 1;64(1):49-73. doi: 10.1111/rssc.12067.
2
Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trials.针对存在协变量缺失的分层标记特定比例风险模型的假设检验及其在HIV疫苗疗效试验中的应用。
Biom J. 2018 May;60(3):516-536. doi: 10.1002/bimj.201700002. Epub 2018 Feb 28.
3
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks.具有缺失标记的分层特定标记比例风险模型的估计
Scand Stat Theory Appl. 2012 Mar;39(1):34-52. doi: 10.1111/j.1467-9469.2011.00746.x.
4
Estimation of Stratified Mark-Specific Proportional Hazards Models under Two-Phase Sampling with Application to HIV Vaccine Efficacy Trials.两阶段抽样下分层标记特定比例风险模型的估计及其在HIV疫苗疗效试验中的应用
Stat Biosci. 2017 Jun;9(1):259-283. doi: 10.1007/s12561-016-9177-5. Epub 2016 Oct 27.
5
Mark-specific hazard ratio model with missing multivariate marks.具有缺失多变量标记的特定标记风险比模型。
Lifetime Data Anal. 2016 Oct;22(4):606-25. doi: 10.1007/s10985-015-9353-9. Epub 2015 Oct 28.
6
A Hybrid Approach for the Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy Trials.一种针对具有缺失协变量和缺失标记的分层标记特定比例风险模型的混合方法及其在疫苗效力试验中的应用
J R Stat Soc Ser C Appl Stat. 2020 Aug;69(4):791-814. doi: 10.1111/rssc.12417. Epub 2020 May 22.
7
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.具有多变量连续标记的标记特异性风险比模型:在疫苗效力中的应用
Biometrics. 2013 Jun;69(2):328-37. doi: 10.1111/biom.12016. Epub 2013 Feb 19.
8
Mark-specific additive hazards regression with continuous marks.具有连续标记的标记特定相加风险回归。
Lifetime Data Anal. 2017 Jul;23(3):467-494. doi: 10.1007/s10985-016-9369-9. Epub 2016 May 11.
9
Estimation of conditional cumulative incidence functions under generalized semiparametric regression models with missing covariates, with application to analysis of biomarker correlates in vaccine trials.广义半参数回归模型下缺失协变量时条件累积发病率函数的估计及其在疫苗试验生物标志物相关性分析中的应用
Can J Stat. 2023 Mar;51(1):235-257. doi: 10.1002/cjs.11693. Epub 2022 Feb 24.
10
Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.带有多元连续标记的标记特异性比例风险模型及其在 HIV 疫苗功效试验中的应用。
Biostatistics. 2013 Jan;14(1):60-74. doi: 10.1093/biostatistics/kxs022. Epub 2012 Jul 3.

引用本文的文献

1
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.两项预防 HIV-1 感染的中和抗体随机临床试验
N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.
2
A Hybrid Approach for the Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy Trials.一种针对具有缺失协变量和缺失标记的分层标记特定比例风险模型的混合方法及其在疫苗效力试验中的应用
J R Stat Soc Ser C Appl Stat. 2020 Aug;69(4):791-814. doi: 10.1111/rssc.12417. Epub 2020 May 22.
3
Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.分析具有缺失原因的特定原因危害函数的时变 Cox 模型。
Lifetime Data Anal. 2020 Oct;26(4):731-760. doi: 10.1007/s10985-020-09497-y. Epub 2020 Apr 9.
4
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment.结合病毒遗传学和统计建模提高 HIV-1 感染时间估计,以增强疫苗效力评估。
Viruses. 2019 Jul 3;11(7):607. doi: 10.3390/v11070607.
5
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features.通过 HIV-1 gp160 序列特征预测 VRC01 中和敏感性。
PLoS Comput Biol. 2019 Apr 1;15(4):e1006952. doi: 10.1371/journal.pcbi.1006952. eCollection 2019 Apr.
6
Estimation of a Semiparametric Varying-Coefficient Mixed Regressive Spatial Autoregressive Model.半参数变系数混合回归空间自回归模型的估计
Econom Stat. 2019 Jan;9:140-155. doi: 10.1016/j.ecosta.2017.05.005. Epub 2017 Jun 9.
7
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.对HVTN 505中突破性HIV-1序列的筛分分析确定了针对Env-gp120 CD4结合位点的疫苗压力。
PLoS One. 2017 Nov 17;12(11):e0185959. doi: 10.1371/journal.pone.0185959. eCollection 2017.
8
Estimation of Stratified Mark-Specific Proportional Hazards Models under Two-Phase Sampling with Application to HIV Vaccine Efficacy Trials.两阶段抽样下分层标记特定比例风险模型的估计及其在HIV疫苗疗效试验中的应用
Stat Biosci. 2017 Jun;9(1):259-283. doi: 10.1007/s12561-016-9177-5. Epub 2016 Oct 27.
9
Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine Efficacy.通过重新校准特定类型疫苗效力的基线协变量和中间反应终点效应修饰因子来预测新环境中的总体疫苗效力。
Epidemiol Methods. 2016 Dec;5(1):93-112. doi: 10.1515/em-2015-0007. Epub 2016 Jan 23.
10
Mark-specific additive hazards regression with continuous marks.具有连续标记的标记特定相加风险回归。
Lifetime Data Anal. 2017 Jul;23(3):467-494. doi: 10.1007/s10985-016-9369-9. Epub 2016 May 11.

本文引用的文献

1
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks.具有缺失标记的分层特定标记比例风险模型的估计
Scand Stat Theory Appl. 2012 Mar;39(1):34-52. doi: 10.1111/j.1467-9469.2011.00746.x.
2
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.增加 HIV-1 疫苗对具有 Env V2 遗传特征的病毒的功效。
Nature. 2012 Oct 18;490(7420):417-20. doi: 10.1038/nature11519. Epub 2012 Sep 10.
3
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.泰国 RV144 HIV 疫苗功效试验的统计解读:功效试验中统计问题的案例研究。
J Infect Dis. 2011 Apr 1;203(7):969-75. doi: 10.1093/infdis/jiq152.
4
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.疫苗接种对 STEP 试验中突破性 HIV-1 序列的遗传影响。
Nat Med. 2011 Mar;17(3):366-71. doi: 10.1038/nm.2316. Epub 2011 Feb 27.
5
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
6
PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS.具有连续标记的比例风险模型
Ann Stat. 2009 Feb 1;37(1):394-426. doi: 10.1214/07-AOS554.
7
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.有限的中和抗体特异性驱动HIV-1 C亚型早期感染中的中和逃逸。
PLoS Pathog. 2009 Sep;5(9):e1000598. doi: 10.1371/journal.ppat.1000598. Epub 2009 Sep 18.
8
HIV vaccine research: the way forward.HIV疫苗研究:前进之路。
Science. 2008 Jul 25;321(5888):530-2. doi: 10.1126/science.1161000.
9
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.基于连续标记的失效率的双样本问题:在疫苗效力中的应用。
Biostatistics. 2008 Apr;9(2):263-76. doi: 10.1093/biostatistics/kxm028. Epub 2007 Aug 17.
10
HIV-specific probabilistic models of protein evolution.HIV 特异性蛋白质进化概率模型。
PLoS One. 2007 Jun 6;2(6):e503. doi: 10.1371/journal.pone.0000503.